Literature DB >> 15377882

Development and initial characterization of xenomitochondrial mice.

I A Trounce1, M McKenzie, C A Cassar, C A Ingraham, C A Lerner, D A Dunn, C L Donegan, K Takeda, W K Pogozelski, R L Howell, C A Pinkert.   

Abstract

Xenomitochondrial mice harboring trans-species mitochondria on a Mus musculus domesticus (MD) nuclear background were produced. We created xenomitochondrial ES cell cybrids by fusing Mus spretus (MS), Mus caroli (MC), Mus dunni (Mdu), or Mus pahari (MP) mitochondrial donor cytoplasts and rhodamine 6-G treated CC9.3.1 or PC4 ES cells. The selected donor backgrounds reflected increasing evolutionary divergence from MD mice and the resultant mitochondrial-nuclear mismatch targeted a graded respiratory chain defect. Homoplasmic (MS, MC, Mdu, and MP) and heteroplasmic (MC) cell lines were injected into MD ova, and liveborn chimeric mice were obtained (MS/MD 18 of 87, MC/MD 6 of 46, Mdu/MD 31 of 140, and MP/MD l of 9 founder chimeras, respectively). Seven MS/MD, 1 MC/MD, and 11 Mdu/MD chimeric founder females were mated with wild-type MD males, and 18 of 19 (95%) were fertile. Of fertile females, only one chimeric MS/MD (1% coat color chimerism) and four chimeric Mdu/MD females (80-90% coat color chimerism) produced homoplasmic offspring with low efficiency (7 of 135; 5%). Four male and three female offspring were homoplasmic for the introduced mitochondrial backgrounds. Three male and one female offspring proved viable. Generation of mouse lines using additional female ES cell lineages is underway. We hypothesize that these mice, when crossbred with neurodegenerative-disease mouse models, will show accelerated age-related neuronal loss, because of their suboptimal capacity for oxidative phosphorylation and putatively increased oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377882     DOI: 10.1023/B:JOBB.0000041778.84464.16

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  17 in total

1.  Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells.

Authors:  I Trounce; J Schmiedel; H C Yen; S Hosseini; M D Brown; J J Olson; D C Wallace
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice.

Authors:  J E Sligh; S E Levy; K G Waymire; P Allard; D L Dillehay; S Nusinowitz; J R Heckenlively; G R MacGregor; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

Review 4.  The role of mitochondria in the pathogenesis of neurodegenerative diseases.

Authors:  G Manfredi; M F Beal
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

5.  Transfer of chloramphenicol-resistant mitochondrial DNA into the chimeric mouse.

Authors:  S E Levy; K G Waymire; Y L Kim; G R MacGregor; D C Wallace
Journal:  Transgenic Res       Date:  1999-04       Impact factor: 2.788

6.  Isolation and microinjection of somatic cell-derived mitochondria and germline heteroplasmy in transmitochondrial mice.

Authors:  M H Irwin; L W Johnson; C A Pinkert
Journal:  Transgenic Res       Date:  1999-04       Impact factor: 2.788

7.  Mitochondria transfer into mouse ova by microinjection.

Authors:  C A Pinkert; M H Irwin; L W Johnson; R J Moffatt
Journal:  Transgenic Res       Date:  1997-11       Impact factor: 2.788

8.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

Authors:  R E Heikkila; A Hess; R C Duvoisin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

9.  Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.

Authors:  Patricia A Trimmer; Paula M Keeney; M Kate Borland; Frederic A Simon; Jatanna Almeida; Russell H Swerdlow; Janice P Parks; W Davis Parker; James P Bennett
Journal:  Neurobiol Dis       Date:  2004-02       Impact factor: 5.996

10.  Severe reversible cardiomyopathy in four unrelated infants associated with mitochondrial DNA D-loop heteroplasmy.

Authors:  R G Boles; C Luna; M Ito
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

View more
  7 in total

Review 1.  Evolution of the couple cytochrome c and cytochrome c oxidase in primates.

Authors:  Denis Pierron; Derek E Wildman; Maik Hüttemann; Thierry Letellier; Lawrence I Grossman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Near neutrality: leading edge of the neutral theory of molecular evolution.

Authors:  Austin L Hughes
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 3.  Mitochondrial biology in reproduction.

Authors:  Matthew V Cannon; Kumiko Takeda; Carl A Pinkert
Journal:  Reprod Med Biol       Date:  2011-08-03

Review 4.  Animal models of human mitochondrial DNA mutations.

Authors:  David A Dunn; Matthew V Cannon; Michael H Irwin; Carl A Pinkert
Journal:  Biochim Biophys Acta       Date:  2011-08-11

5.  Xenomitochondrial mice: investigation into mitochondrial compensatory mechanisms.

Authors:  M V Cannon; D A Dunn; M H Irwin; A I Brooks; F F Bartol; I A Trounce; C A Pinkert
Journal:  Mitochondrion       Date:  2010-07-16       Impact factor: 4.160

6.  The mitochondrial genome sequence of Mus terricolor: comparison with Mus musculus domesticus and implications for xenomitochondrial mouse modeling.

Authors:  Wendy K Pogozelski; Leah D Fletcher; Carolyn A Cassar; David A Dunn; Ian A Trounce; Carl A Pinkert
Journal:  Gene       Date:  2008-04-10       Impact factor: 3.688

Review 7.  Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT.

Authors:  R Tayfur Tecirlioglu; Jitong Guo; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.